New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Withdrawn

Conditions

Renal Insufficiency, Acute

Study type

Observational

Funder types

Other

Identifiers

NCT00855127
08-0769

Details and patient eligibility

About

The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.

Full description

Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 [IL-18] and urine neutrophil gelatinase associated lipocalin [NGAL]) can predict the outcome measures listed above.

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First time liver transplant recipient
  • Cadaveric or living donor livers

Exclusion criteria

  • Unconscious patients or patients who cannot give consent
  • Pregnant women
  • Prisoners
  • Patients receiving dialysis before or during liver transplant operation
  • Patients receiving simultaneous liver-kidney transplants

Trial design

0 participants in 1 patient group

Liver transplant recipients

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems